EP Patent

EP1077683B1 — Antidepressant therapy

Assigned to Alza Corp · Expires 2002-12-11 · 23y expired

What this patent protects

An osmotic dosage from is disclosed for delivering an antidepressant for treating depression in a patient in need of antidepressant therapy.

USPTO Abstract

An osmotic dosage from is disclosed for delivering an antidepressant for treating depression in a patient in need of antidepressant therapy.

Drugs covered by this patent

Patent Metadata

Patent number
EP1077683B1
Jurisdiction
EP
Classification
—
Expires
2002-12-11
Drug substance claim
No
Drug product claim
No
Assignee
Alza Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.